# Cipla Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82

> Inspection records and compliance data for Cipla Ltd. in Bangalore, None. Access full analysis and detailed observations.

---

## Details

- Name: Cipla Ltd.
- FEI Number: 3005857289
- City: Bangalore
- State: None
- Country Name: India
- Address Line 1: 285, 286 and 287, KIADB, IV Phase, Bommasandra-Jigani Link Road
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Cipla Ltd. - Unknown Date](https://www.keypedia.com/records/483/cipla-ltd/3f8962ce-3c66-4db6-96ea-a709462fa3a3) — source: FDA, date: Invalid Date
- [FDA Inspection 1271320 - Cipla Ltd. - 2025-05-30](https://www.keypedia.com/records/fda_inspections/cipla-ltd/07e0b1bd-cab9-4422-8834-b1e0ebb55d3e) — source: FDA, date: May 30, 2025
- [FDA Inspection 1271320 - Cipla Ltd. - 2025-05-30](https://www.keypedia.com/records/fda_inspections/cipla-ltd/0b1d5c3a-cab6-4504-b566-6362219eb0e0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2025
- [483 - Cipla Ltd. - 2025-05-26](https://www.keypedia.com/records/483/cipla-ltd/1e5d4e6e-c770-4dc1-bfc6-14c2d583e30c) — source: FDA, date: May 26, 2025
- [FDA Inspection 1117627 - Cipla Ltd. - 2020-01-24](https://www.keypedia.com/records/fda_inspections/cipla-ltd/918145f8-0e2e-4fbf-8733-3d6639a9d001) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2020
- [483 - Cipla Ltd. - 2020-01-20](https://www.keypedia.com/records/483/cipla-ltd/188882e0-4d67-4abb-bd52-e0728ee71ad4) — source: FDA, date: January 20, 2020
- [FDA Inspection 921236 - Cipla Ltd. - 2015-03-12](https://www.keypedia.com/records/fda_inspections/cipla-ltd/d528b206-bdf2-4811-88b5-49dda94f10d3) — classification: No Action Indicated (NAI), source: FDA, date: March 12, 2015
- [FDA Inspection 768491 - Cipla Ltd. - 2011-11-17](https://www.keypedia.com/records/fda_inspections/cipla-ltd/6f02ef12-1475-47c2-a395-592976ffb865) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2011

## Related Companies

- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf)
- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/3aa20920-7f85-4cd2-806b-a3cfb4548be8)
- [Shilpa Pharma Lifesciences Limited](https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)
- [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6)

## Related Officers

- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)
- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Mr. Aron Shapiro](https://www.keypedia.com/people/mr-aron-shapiro/4e7e6c39-4aa7-4cdc-8a62-620b3479374c)